Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 24.47 Million CAD | -8.68% |
| 2022 | 26.8 Million CAD | -70.56% |
| 2021 | 91.02 Million CAD | -48.17% |
| 2020 | 175.61 Million CAD | 3844.78% |
| 2019 | 4.45 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 23.43 Million CAD | -4.25% |
| 2024 Q2 | 24.07 Million CAD | 2.75% |
| 2023 Q1 | 79.07 Million CAD | 195.04% |
| 2023 FY | 24.47 Million CAD | -8.68% |
| 2023 Q3 | 67.33 Million CAD | -3.42% |
| 2023 Q4 | 24.47 Million CAD | -63.65% |
| 2023 Q2 | 69.71 Million CAD | -11.83% |
| 2022 Q3 | 89.09 Million CAD | 0.0% |
| 2022 Q4 | 26.8 Million CAD | -69.92% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bioxytran, Inc. | 137.63 Thousand USD | -17682.732% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 36.994% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -31955.684% |
| SQZ Biotechnologies Company | 107.18 Million USD | 77.165% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -1609.166% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -131.91% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 81.203% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -33722.7% |
| Marizyme, Inc. | 22.01 Million USD | -11.177% |
| Genus plc | 1.02 Billion USD | 97.621% |
| Pharming Group N.V. | 462.85 Million USD | 94.712% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -638.778% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -4804.586% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -3803.636% |
| ContraFect Corporation | 20.67 Million USD | -18.361% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -6304.309% |
| IMV Inc. | 31.33 Million USD | 21.887% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -490.344% |
| ONE Bio Corp. | 70.08 Million USD | 65.077% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 80.954% |
| Mesoblast Limited | 667.9 Million USD | 96.335% |
| MultiCell Technologies, Inc. | 126.22 USD | -19391277.753% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 30.425% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.277% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -3076.019% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -9267.758% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -239.011% |
| Biomind Labs Inc. | 73.81 Thousand USD | -33056.5% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -1589.334% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 18.455% |
| Skye Bioscience, Inc. | 11.94 Million USD | -104.983% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1701.873% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -791.217% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -6169.961% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -1149.92% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -3460.188% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -2504.67% |
| EV Biologics, Inc. | 431.71 Thousand USD | -5569.447% |
| Q BioMed Inc. | 3.51 Million USD | -596.222% |
| GB Sciences, Inc. | 103.44 Thousand USD | -23561.373% |
| Alpha Cognition Inc. | 2.45 Million USD | -898.128% |
| CSL Limited | 38.02 Billion USD | 99.936% |
| Agentix Corp. | 261.39 Thousand USD | -9263.637% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 94.516% |
| Enzolytics Inc. | 361.7 Million USD | 93.233% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 8.11 Million USD | -201.612% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -1203.374% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -840.221% |
| argenx SE | 4.54 Billion USD | 99.461% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 12.411% |
| HST Global, Inc. | 1526.00 USD | -1603818.545% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 48.69% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -2377.39% |
| Halberd Corporation | 10.13 Thousand USD | -241493.1% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -3726.4% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -173.498% |
| Zenith Capital Corp. | 7410.00 USD | -330207.652% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -107339.52% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -7505.762% |
| AVAX Technologies, Inc. | 7.37 Million USD | -231.778% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -9264.64% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -2537.589% |
| Ember Therapeutics, Inc. | 184.00 USD | -13301963.587% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -39219.813% |
| Helix BioMedix, Inc. | 3.02 Million USD | -709.094% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 53.557% |
| Kadimastem Ltd | 2.3 Million USD | -962.281% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -68.1% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -42769.298% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -1059458.312% |
| LadRx Corporation | 2.3 Million USD | -960.531% |
| Cell Source, Inc. | 195.17 Thousand USD | -12440.694% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -4993.214% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -6821.556% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -6821.556% |
| Affymax, Inc. | 7.44 Million USD | -228.843% |
| Mobile Lads Corp. | 52.00 USD | -47068740.385% |
| Itoco Inc. | 1.4 Million USD | -1648.181% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -25487.042% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -22990.375% |
| International Stem Cell Corporation | 5.39 Million USD | -354.096% |
| CytoDyn Inc. | 11.13 Million USD | -119.79% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -17019.294% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -136789.245% |
| Qrons Inc. | 420.00 USD | -5827470.714% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -6249.582% |
| SYBLEU INC | 330.46 Thousand USD | -7306.405% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -4333.057% |
| Rebus Holdings, Inc. | 5000.00 USD | -489415.94% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -5878.134% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -63.152% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -47.631% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -30882.022% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -2730.629% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -225.606% |
| Neutra Corp. | 2851.00 USD | -858398.667% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 24.471% |
| PureTech Health plc | 693.97 Million USD | 96.473% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -203.253% |
| IXICO plc | 15.84 Million USD | -54.481% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -195.53% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 76.312% |
| CSL Limited | 38.02 Billion USD | 99.936% |
| Cellectis S.A. | 333.99 Million USD | 92.672% |